All payments made in the preview are in test mode. Read more
Sign in
Back to Atlas
CTransientPrescription / clinician-supervised
CMP-0964
Prescription/approved or clinician-supervised in some jurisdictions

Finasteride

Endocrine modulation

Hormonal-axis, androgen/estrogen, or reproductive modulation

Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type
Endocrine / hormone-modulating compound
Primary mechanism
Steroid hormone receptor or enzyme modulation
Primary market use
Endocrine modulation

Pharmacology

Oral bioavailability
Route-dependent / verify
Half-life
~5–6 h
Route tags
Route-dependent / verify
Evidence level
Research-chemical/vendor catalog signal
Clinical status
Prescription/approved or clinician-supervised in some jurisdictions
Value-for-money score
3 / 10

Reported protocol signal

Prescription oral use; commonly 1 mg/day for hair loss or 5 mg/day for BPH.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Candidate from source website product/category listing

Educational and organizational assistant matrix. Not medical advice.

BioChrysalis Atlas is an educational, organizational, and tracking asset. It does not provide medical advice, diagnosis, treatment, prescriptions, or individualized dosing instructions. Compound profiles, protocol notes, and dosage fields summarize publicly discussed or source-listed reference patterns and are not recommendations. Consult a qualified healthcare professional before starting, stopping, or modifying any compound, medication, or supplement protocol.

© BioChrysalis · Evolve · Ascend · Transcend